Recent Updates
Recently added Catalysts
INO Positive Sentiment Score: 70/100

INOVIO to Participate in December Investor Conferences

Tuesday, November 18, 2025 1 min read
Key Takeaway: INOVIO Pharmaceuticals, a biotech firm specializing in DNA medicines, announced its participation in two upcoming investor conferences in December. The events include the Piper Sandler 37th Annual Healthcare Conference and the Oppenheimer Movers in Rare Disease Summit. Management will also hold one-on-one meetings with investors to discuss potential catalysts.

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is actively engaging with investors at key conferences.
  • Participation in notable events like the Piper Sandler Conference.
  • Opportunities for one-on-one meetings with management team.

Full Press Release Details

PLYMOUTH MEETING, Pa.,Nov. 18, 2025/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:

Piper Sandler 37th Annual Healthcare Conference (New York, NY)Date:Tuesday, December 2Time:8:30-8:55 AM ETFormat:Fireside ChatWebcast:https://bit.ly/44af19l(live webcast and replay available for 90 days after the event)

Oppenheimer Movers in Rare Disease Summit (New York, NY)Date:Thursday, December 11Time:12:05-12:25 PM ETFormat:Panel -Elevator Pitches from Rare Disease Companies with Key Near-Term, Potentially Stock-Moving Catalysts

Members of INOVIO's management team will also be conducting one-on-one meetings with investors during these conferences.

About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visitwww.inovio.com.

ContactsMedia: Jennie Willson, (267) 429-8567,[email protected]Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505,[email protected]

SOURCE INOVIO Pharmaceuticals, Inc.

Frequently Asked Questions

What conferences will INOVIO participate in December?

INOVIO will participate in the Piper Sandler Healthcare Conference and the Oppenheimer Movers in Rare Disease Summit.

When is the Piper Sandler Conference?

The Piper Sandler 37th Annual Healthcare Conference is on December 2, from 8:30 to 8:55 AM ET.

What is the format of the Oppenheimer Summit?

The Oppenheimer Movers in Rare Disease Summit will feature panel discussions and elevator pitches from rare disease companies.

Will INOVIO hold one-on-one meetings?

Yes, INOVIO's management team will conduct one-on-one meetings with investors during the conferences.

Tags: INO Viatris Investor Conferences Healthcare INOVIO investor conferences DNA medicines HPV rare diseases
Last updated: Nov 18, 2025